(RTTNews) - Teleflex Incorporated (TFX) announced the completion of patient enrollment in the BIOMAG-LL Clinical Study, evaluating the safety and clinical performance of 35 mm and 40 mm Freesolve Resorbable Magnesium Scaffolds for treating long coronary lesions.

Teleflex Completes Enrollment In BIOMAG-LL Study Of Longer Freesolve Resorbable Scaffolds 

QGEN's test menu expansion and strategic partnerships support growth, but cautious spending and competition may weigh on near-term gains.

Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now

ILMN's 94.9% YTD rally reflects strong sequencing growth, clinical adoption and a raised 2026 outlook despite China headwinds.

Illumina Stock Surges 94.9% YTD: What's Behind the Rally?

PEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.

Reasons to Retain Penumbra Stock in Your Portfolio for Now

TFX vs. PEN: Which Stock Is the Better Value Option?

EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.

Should You Hold Edwards Lifesciences Stock in Your Portfolio?

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Teleflex Incorporated News